GlaxoSmithKline


Recent News About GlaxoSmithKline View More

SCOTUS decision could mean new hearing for widow's suit vs GSK over suicide of lawyer taking generic Paxil

By Jonathan Bilyk | May 21, 2019

A federal appeals court in Chicago could be tasked with taking another look at its previous decision undoing a jury verdict ordering drug maker GSK to pay $3 million to the widow of a Chicago lawyer who committed suicide after taking the generic equivalent of a widely prescribed antidepressant drug.

SCOTUS weighs competing briefs in widow's appeal in case vs GSK over suicide of lawyer taking generic Paxil

By Jonathan Bilyk | Apr 17, 2019

The U.S. Supreme Court is tackling the question of whether drug companies can be sued for not making their warning labels strong enough, even though the FDA controls the labels. But whether a forthcoming Supreme Court decision will affect a decision denying a $3 million judgment to the widow of a Chicago lawyer who committed suicide after taking the generic equivalent of Paxil remains unclear.

Massachusetts product liability ruling may have bearing on GSK appeal of $3M verdict over lawyer's suicide

By Karen Kidd | Apr 13, 2018

The thinking behind a Massachusetts ruling that brand-name manufacturers can he held liable for injuries suffered by patients who take generic versions of the drug those manufacturers innovate could have bearing in a case before a federal appeals court in Chicago.

The Record Network